Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
This study exists to understand what helps this type of care work in everyday practice, not just under ideal conditions. Researchers are trying to understand how people respond to this type of care in practice and what may need to be adjusted.
In United States
This study is completed in the United States. It focuses on schizophrenia.
In United StatesThis study is completed in the United States. It is testing TAK-063 for schizophrenia.
In United StatesThis study was terminated in the United States. It focuses on ADHD.
In United StatesThis study is completed in the United States. It is testing BNC210 for anxiety.
In United StatesThis study is completed in the United States. It is testing ABT-126 for schizophrenia.
In United StatesThis study is completed in the United States. It is testing Safety and Efficacy of CTP-692 for schizophrenia.
In United StatesThis summary needs review. Please check the official study record and contact the research team for details.
In United StatesThis study was terminated in the United States. It is testing TNX-102 SL for PTSD.
In United StatesThis study is active but not recruiting in the United States. It focuses on anxiety.
In United StatesThis study is active but not recruiting in the United States. It focuses on depression.
In United StatesThis study is active but not recruiting in the United States, in France, in the United Kingdom, .... It focuses on anxiety.
In United StatesHopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.